SECsense Logo

Bionano Genomics 8-K Filing: Significant Corporate Update on February 21, 2025

$BNGO
Form 8-K
Filed on: 2025-02-21
Source
Bionano Genomics 8-K Filing: Significant Corporate Update on February 21, 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Company Information:
  • Name: Bionano Genomics, Inc.
  • CIK (Central Index Key): 0001411690
  • SEC File Number: 001-38613
  • EIN (Employer Identification Number): 26-1756290
  • Address: 9540 Towne Centre Drive, Suite 100, San Diego, CA 92121
  • Phone Number: 858-888-7600
  1. Filing Type:
  • Form: 8-K (a report of unscheduled material events or corporate changes)
  1. Filing Date:
  • Date: February 21, 2025
  1. Stock Information:
  • Ticker Symbol: BNGO
  • Exchange: NASDAQ
  • Common Stock: Par value of $0.0001 per share
  1. Period:
  • Start Date: February 21, 2025
  • End Date: February 21, 2025
  1. XBRL Information:
  • The document is in XBRL format, which is an XML-based format for financial reporting.
  1. Context Information:
  • The context ID associated with this filing is "c20250221to20250221".

Insights:

  • The report is a current event filing (8-K) indicating that Bionano Genomics may have had a significant event on the filing date. Stakeholders should look for details in the complete filing to understand the nature of the event.
  • The company is publicly traded on NASDAQ under the ticker BNGO, which provides context for its market performance and investor interest.
  • The report indicates compliance with SEC regulations by using standard identifiers and formats, which is crucial for transparency and accuracy in financial reporting.

This information can be particularly valuable for investors, analysts, and other stakeholders monitoring Bionano Genomics for developments or changes in corporate status.